At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
In the news
6 articles- Lawmakers propose China restrictions; #ASCO26 recap; and moreEndpoints News·2026-06-06
- What’s next for VEGF? #ASCO26 offered clues, but answers will have to waitEndpoints News·2026-06-02
- #ASCO26: Celcuity plans another FDA filing after positive breast cancer readoutEndpoints News·2026-06-02
- #ASCO26: Roche details narrow failure of breast cancer pill trialEndpoints News·2026-06-02
- #ASCO26: Lilly's plenaries; Incyte's frontline data in lymphomaEndpoints News·2026-06-01
- #ASCO26: Kelonia Therapeutics delivers an impressive in vivo CAR-T updateEndpoints News·2026-06-01
Matched to this trial by ClinicalIndexfrom reputable biotech & medical press.
The Prognostic Relevance of N-terminal Pro B-type Natriuretic Peptide(NTproBNP), Cerebral Oxygen Saturation (ScO2), and Preoperative Creatinine Clearance in Cardiac Surgery Patients - Amendment 2: the Role of NTproBNP and ScO2 in Predicting Mortality and Postoperative Organ Dysfunction.
In Brief
An observational study for Patients Undergoing Cardiac Surgery. Completed, enrolled 765 participants.
Detailed Summary
Cerebral oxygen saturation (ScO2) is a measure of cerebral and systemic oxygen delivery to demand ratio. An observational trial in a heterogeneous cohort of 1078 patients patients revealed that a ScO2 below 50% absolute during oxygen insufflation is an independent predictor of short and long term mortality in patients undergoing on-pump cardiac surgery. Comparably, a low ScO2 was a predictor of postoperative morbidity determined as a combined endpoint of a high dependency unit stay of more than 9 days and/or at least 2 of the major postoperative complications. low cardiac output syndrome, stroke, need of renal replacement therapy or reintubation. The primary objectives of the present prospective observational study is to determine, if there is an association between preoperative ScO2 and postoperative organ dysfunction determined by sensitive markers of organ dysfunction (N-Terminal pro B-type natriuretic peptide, high sensitive troponin T, growth-differentiation factor 15, soluble -FLT1, and placental growth factor)